0001181431-12-005291.txt : 20120202 0001181431-12-005291.hdr.sgml : 20120202 20120202163117 ACCESSION NUMBER: 0001181431-12-005291 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120201 FILED AS OF DATE: 20120202 DATE AS OF CHANGE: 20120202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WORTZMAN MARILYN E CENTRAL INDEX KEY: 0001235962 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51967 FILM NUMBER: 12566295 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Transcept Pharmaceuticals Inc CENTRAL INDEX KEY: 0001178711 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330960223 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1003 W. CUTTING BLVD STREET 2: SUITE 110 CITY: POINT RICHMOND STATE: CA ZIP: 94804 BUSINESS PHONE: (510) 215-3500 MAIL ADDRESS: STREET 1: 1003 W. CUTTING BLVD STREET 2: SUITE 110 CITY: POINT RICHMOND STATE: CA ZIP: 94804 FORMER COMPANY: FORMER CONFORMED NAME: NOVACEA INC DATE OF NAME CHANGE: 20020724 4 1 rrd332258.xml WORTZMAN ANNUAL GRANT X0304 4 2012-02-01 0 0001178711 Transcept Pharmaceuticals Inc TSPT 0001235962 WORTZMAN MARILYN E C/O TRANSCEPT PHARMACEUTICALS, INC. 1003 W. CUTTING BLVD, SUITE 110 POINT RICHMOND CA 94804 0 1 0 0 VP, Finance Employee Stock Option (right to buy) 8.09 2012-02-01 4 A 0 30000 0 A 2022-02-01 Common Stock 30000 30000 D The option vests in forty-eight equal monthly installments beginning March 1, 2012. /s/ Marilyn Wortzman 2012-02-02